Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Undetectable IgE as Biomarker for Immunodeficiency
NCT03968211Phase 1Completed
- Sponsor
- University of Virginia
- Start
- Jul 2019
- Primary completion
- Dec 2023
- Modality
- Split/Subunit Vaccines, Recombinant Protein Vaccines
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of salmonella typhi capsular polysaccharide vaccine in typhoid fever, sponsored by University of Virginia. Primary endpoint: Vaccination response. Started Jul 2019; status: completed.
02
Drugs
salmonella typhi capsular polysaccharide vaccine
03
Conditions
typhoid fever
Beyond the preview
Go deeper on NCT03968211.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03968211.